Vaccine

National Minority Quality Forum Urges Policymakers to Ensure Equitable Access to New Respiratory Syncytial Virus Immunizations

Health Equity Action Report shows low-income children of color are at high risk of severe RSVWashington, D.C.--(Newsfile Corp. - July…

1 year ago

Vytalize Health Launches Charitable Initiative to Relieve Medical Debt Burden

Initial donation to RIP Medical Debt will erase $2 million in debt for families living on Long Island, furthering Vytalize…

1 year ago

Dyadic Provides Phase 1 Clinical Trial Update for its Recombinant Protein RBD Vaccine Candidate

Dosing of patients completed at the end of FebruaryData Safety Monitoring Board conducted analysis of Day 29 data No major…

1 year ago

BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023

MAINZ, Germany, July 24, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial…

1 year ago

Bavarian Nordic Provides Update on RSV Vaccine Program

Phase 3 study failed to meet one of the success criteria of the primary objectiveRSV program to be discontinuedCOPENHAGEN, Denmark,…

1 year ago

Emergex Reports Promising Data from Completed Swiss Phase I Trial of CoronaTcP™, T Cell-Priming Immune Set-Point Candidate for Betacoronaviruses

First-in-human intradermal administration of CoronaTcP™ was generally well-toleratedEvidence for generation of virus-specific effector and memory CD8+ T cellsData reinforce findings…

1 year ago